ABSTRACT -Cadmium (Cd) is classified as an environmental pollutant and human carcinogen. Caffeic acid phenethyl ester (CAPE), a biological active component of honeybee propolis extracts, has been used as a folk medicine with no harmful effects on normal cells. Here we investigated the beneficial effect of CAPE on Cd-induced renal damage in mice. Since renal damage induced by Cd (II) is related to oxidative stress, lipid peroxidation (LPO), protein carbonyl (PCO), superoxide dismutase (SOD), catalase (CAT) and glutathione (GSH) were evaluated. Moreover, the concentrations of Cd and zinc (Zn) in the kidney were analyzed. The intoxication of Cd (II) leads to the enhanced production of LPO and PCO, and the decrease of SOD activity and GSH level, probably due to the serious oxidative stress. However, the activities of CAT in the Cd (II)-induced group showed an elevated tendency, probably relating to an adaptive-response to the oxidative damage. The co-administration of CAPE can attenuate the oxidative stress caused by the intoxication of Cd and restore the altered antioxidant defense system. Based on our data, it is proposed that CAPE may involve in the protection of renal damage induced by Cd (II) owing to its antioxidant capacity and anti-inflammatory effect.
INTRODUCTION
Cadmium (Cd), an important industrial metal, has been classified as an environmental pollutant and human carcinogen (IARC, 1993) . Food is the major source of Cd exposure for the general population, and cigarette smoking significantly adds to the body burden of Cd (Klaassen et al., 1999) . Occupational exposure is mainly from Cd fume inhalation, cadmium-nickel battery industry, electroplating, and paint pigments . Acute Cd poisoning is toxic to a number of tissues, among them, kidney and liver have been considered as the most targeted organs. The intoxication of Cd causes pulmonary edema, hemorrhage, fulminate hepatitis, testicular injury, and lethality. Prolonged exposure to Cd produces nephrotoxicity, osteotoxicity, and immunotoxicity . One of the main reasons for the negative influence of Cd is its accumulation in the tissues and its long biological half life (15-20 years) (Jin et al., 2004) .
Although several mechanisms have been proposed to explain the Cd-induced toxicity, no mechanisms have been yet defined explicitly. Various studies suggested oxidative stress as one of the important mechanisms of toxic effects of Cd, since oxidative stress has been implicated to contribute to Cd-associated tissue injury in the liver, kidneys, brain and other organs. Oxidative stress causes depletion in the levels of reduced glutathione, an alteration in the activity of antioxidant enzymes, and a change in the structure of the cellular membrane through a process of lipid peroxidation (Zikic et al., 1996; Bagchi et al., 1997) . Moreover, Cd stimulates the formation of reactive oxygen species (ROS) which enhances lipid peroxidation, protein and DNA damage, calcium and sulfhydryl homeostasis, and disturbance of antioxidant defense system (Leonard et al., 2004; Valko et al., 2005) .
Recently, various studies are focused on the development of suitable reagents to counteract the toxic effect of Cd. Many antioxidants have been attempted to be used in the intervention of Cd (II) toxicity, for instance, asmelatonin (Karbownik et al., 2001) , quercetin (Hu et al., 2001) , hydroxytyrosol (Casalino et al., 2002) , coenzyme Q10 (Eybl et al., 2002) , beta-carotene (El-Demerdash et al., 2004) , curcumin (Eybl et al., 2004) , vitamin E (Nemmiche et al., 2007) and diphenyl diselenide (Borges et al., 2008) . Our group has demonstrated that endomorphin 1, the endogenous μ-opioid receptor agonists (Zadina et al., 1997) , can block the toxicity of Cd and protect mice liver from oxidative damage (Gong et al., 2008) . Although many possible treatment protocols for Cd intoxication have been investigated, few have succeeded in clinical trials. Therefore, novel therapeutic agents with improved effi cacy are needed to ameliorate or counteract the intoxication of Cd.
Caffeic acid phenethyl ester (CAPE), a biological active component of honeybee propolis exacts, is structurally related to flavonoids (shown in Fig. 1 ) and has been used as a folk medicine with no harmful effects on normal cells (Ilhan et al., 1999) . It has been widely used as an antioxidant against various oxidative processes in animal models and elicited numerous biological activities including antiviral, antioxidant, anti-inflammatory, anti-mitogenic and immunomodulatory properties. The physiological and pharmacological properties of CAPE was investigated by us both in vitro and in vivo assays. The structure-activity relationship has been identifi ed by comparing the potency of free radical scavenging (Wu et al., 2007) . Feng et al. (2008) also demonstrated the antioxidant activitiesof CAPE to limit the anoxia-reoxygenation-induced mitochondria damage in vitro. Wang et al. (2008a Wang et al. ( , 2008b ) also investigated the cytoprotection and antigenotoxic effect of CAPE besides its anticancer effect, and proposed the antioxidant effect of CAPE is the reason. Recently, CAPE has been found to protect rats against carbon tetrachloride induced kidney injuries (Ogeturk et al., 2005) , and against Cd-induced cardiac impairment (Mollaoglu et al., 2006) . However, the physiological functions and the underlying protective mechanism of CAPE against Cd-induced renal injury remain totally unclear.
Given the facts that oxidative stress and inflammatory process are critical mediators for Cd intoxication progress, we hypothesized CAPE may act beneficial effect on Cd-induced renal damage. To test this hypothesis, the effect of CAPE on the Cd-induced renal dysfunction in mice was evaluated. We have assessed the oxidative damage parameters and antioxidant defense system indexes in order to clarify the detailed protective mechanism of CAPE on Cd-induced renal damage. This study may provide experimental basis for new drugs design to combat diseases induced by oxidative stress components, such as heavy metals, and open a new utilization direction for CAPE.
MATERIALS AND METHODS

Chemicals
Cadmium chloride (Cd (II)), reduced glutathione (GSH), 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), thiobarbituric acid (TBA), butylated hydroxytoluene (BHT) and 2,4-dinitrophenylhydrazine (DNPH) were obtained from Sigma-Aldrich Chemical Company (St. Louis, MO, USA). CAPE was synthesized in our lab according to the methods reported by Hu et al. (2006) . Analysis of the 1 H NMR and 13 C NMR spectra showed analytical and spectroscopic data in full agreement with its assigned structure (Burker Advance III 400MHz, Burker, Karlsruhe, German). The chemical purity of CAPE was determined by Reverse phase-High performance liquid chromatography (Waters, Milford, MA, USA). All other chemicals were of analytical grade and obtained from standard commercial supplies.
Animal treatments
Male adult Kunming mice (weighing 18-22 g) were obtained from The Fourth Military Medical University. The animals were housed in stainless steel wire bottom cages at the temperature 25-28°C and humidity controlled room with a 12 hr light/dark cycle and free access to standard pellet diet and drinking water. All animals were cared for and experiments were carried out in accordance with the European Community guidelines for the use of experimental animals (86/609/EEC). All the protocols in this study were approved by the Ethics Committee of Shaanxi University of Science and Technology, China.
After an adaptation period of 3 days, mice were allo- (Mukherjee et al., 1988) .The animals were sacrificed by decapitation after the end of the experimentation periods of 7 days treatment. 24 hr after last treatment, kidneys were dissected and frozen at -80°C until the time of assay.
Oxidative stress
LPO was measured by analyzing thiobarbituric acid reactive substances (TBARS) as described by Utley et al. (1967) with slight modifications. Briefly, the tissues were homogenized in chilled 0.05 M phosphate buffer solution (PBS) (pH 7.4). The assay mixture contained 0.375% (w/v) TBA, 15% chilled trichloroacetic acid (TCA), 0.25 M HCl, together with 0.02% (w/v) BHT (1:1, v/v) and 10% homogenate in a total volume of 3.0 ml. This amount of BHT completely prevents the formation of nonspecific TBARS. The mixture was heated at 95°C for 30 min. After cooling with tap-water, 5 ml n-butanol was added and shaken vigorously, the mixture was centrifuged for 15 min at 4,000 × g. The organic layer was taken and the intensity of pink color extracted in the organic phase was determined at 532 nm. The amount of malondialdehyde formed was calculated using molar extinction coefficient of 1.56 × 10 5 M −1 cm −1 . Each sample was assayed in triplicate.
PCO content was estimated by DNPH assay (Levine et al., 1994) . About 0.1 g of kidney was rinsed in 10 mM PBS buffer (pH 7.4) and homogenized with addition of 2.0 ml PBS (pH 7.4). After centrifugation at 10,000 × g for 10 min, 0.5 ml of tissue supernatant was taken into the tubes. In each tube, 0.5 ml of DNPH in 2.0 M HCl was added. Tubes were vortexed every 10 min in the dark for 1 hr. Proteins were then precipitated with 30% TCA and centrifuged at 4,000 × g for 10 min. The pellet was washed three times with 1.0ml of ethanol:ethyl acetate (1:1, v/v). The final pellet was dissolved in 1.0 ml of 6.0 M guanidine hydrogen chloride in 20 mM potassium dihydrogen phosphate (pH 2.3). The absorbance was determined at 370 nm. PCO content was calculated using a molar absorption coefficient of 2.2 × 10 4 M −1 cm −1 .
Antioxidative defence system
GSH content of the kidney was assayed by treating the sample with 10% TCA and then centrifuged. The clear supernatant was treated with DTNB. The GSH content of the kidney was estimated as the non-protein sulfhydryl content according to the method of Ellman (1959) .
CAT assay was adopted from the method of Aebi (1984) , based on the principle that at ultraviolet range H 2 O 2 shows a continual increase in absorption with decreasing wavelength. The rate of H 2 O 2 decomposition was followed by monitoring the absorbance at 240 nm. In this assay, 250 μl of 0.66 M H 2 O 2 , 200 μl of 0.5 M phosphate buffer and 50μl of tissue homogenate were added. Control contained only H 2 O 2 and phosphate buffer. The optical density was measured at 240 nm for 30 sec. One unit of catalase activity is defined as the amount of enzyme required to decompose 1 μmol of hydrogen peroxide in 1 min. The activity was calculated using the extinction coefficient of H 2 O 2 (ε = 0.0394 mM −1 cm −1 ).
SOD activity was determined from its ability to inhibit the autoxidation of pyrogallol using a modification of the method of Marklund and Marklund (1974) . Briefly, samples were assayed in a solution of 3 ml of 50 mM phosphate buffer (pH 8.2) and 10 μl of 50 mM pyrogallol (in 10 mM HCl). The rate of pyrogallol auto-oxidation was measured at 325 nm at 25°C. One unit of enzyme activity was defined as the amount of the enzyme, which gave 50% inhibition of the auto-oxidation rate of 0.1 mM pyrogallol in 1ml of solution at 25°C.
Element analysis
The kidney tissues were weighed and dry-ashed in a muffle furnace. The ash was solubilized with 3M HCl and appropriately diluted. Samples were analyzed for Cd (228.8 nm), Zn (213.9 nm), using a polarized Zeman Atomic Absorption spectrometer (Hitachi Z-200, Hitachi, Tokyo, Japan). The element contents are expressed as micrograms of the element per gram of wet tissue weight (μg/g w.t.w.) (Brzóska et al., 2002; Jurczuk et al., 2003) .
Determination of metallothionein (MT) in kidney
MT content in mouse kidney was determined as described previously with slight modification (Viarengo et al., 1997; Petrovic et al., 2001) . Briefly, tissues were homogenized in ten volumes of 20 mM Tris-HCl buffer, pH 8.6, including 0.5 M sucrose, 0.006 mM leupeptine, 0.5 mM phenylmethylsulphonylfl uoride and 0.01% β-mercaptoethanol. The homogenate was then centrifuged at 30,000 × g for 30 min to obtain a supernatant containing MT. 1.05 ml of cold (-20°C) absolute ethanol and 80 μl of chloroform were added to aliquots of 1 ml of supernatant, the mixture was then centrifuged at 6,000 × g for 10 min at 4°C. The supernatant was combined with three volumes of cold ethanol (-20°C) and maintained at -20°C for 1 hr followed by centrifugation at 6,000 × g for 10 min. The MT -containing pellet was then washed with 87% ethanol and 1% chloroform in homogenizing buffer, centrifuged at 6,000 × g for 10 min and dried under nitrogen gas stream. The pellet was resuspended in 150 μl 0.25 M NaCl and subsequently 150 μl 1N HCl containing 4 mM EDTA 4 mM. 4.2 ml 0.2 M Na-phosphate, pH 8, in the presence of 2 M NaCl and 0.43 mM DTNB was then added to the sample at room temperature. The sample was finally centrifuged at 3,000 × g for 5 min. The supernatant absorbance was evaluated at 412 nm and MT concentration was estimated utilizing reduced GSH as standard and expressed as micrograms of MT per gram of tissue wet weight.
Protein content assay
The protein content was estimated using Coomassie Brilliant Blue (G-250) by the method of Bradford (1976) .
Statistical analysis
Data were expressed as mean ± standard error of mean (S.E.M.). Mean values were statistically compared by one-way analysis of variance (ANOVA) and corresponding Student's t-test, p < 0.05 was taken to be statistically signifi cant.
RESULTS
Infl uence of Cd (II) on the ratio of kidney weight/ mice weight
The effect of Cd (II) on the ratio of mice tissues/ whole mice weight was assessed. As shown in Fig. 2 , the intoxication of Cd (II) blocked the growth of mice and their tissues investigated in this study. Interestingly, the ratio of kidney weight/mice weight is the lowest in the Cd (II) group (p < 0.001, compared with control group), and co-administration of CAPE can reduce this alteration (p < 0.05, compared with Cd (II) group). This suggested that CAPE may have some benefi cial effects on Cd (II)-induced renal damage in mice.
Effect of different doses of CAPE on the Cd (II)-induced renal damage
To provide some direct evidences for the protective roles of CAPE against the renal damage induced by Cd (II) in mice, we examined the oxidative damage parameters and antioxidant defense system indexes.
LPO and PCO
LPO and PCO are two important indicators of oxidative damage of macromolecules by ROS. As presented in Fig. 3 , Cd (II) signifi cantly increased the level of protein carbonyl in the Cd (II) group when comparing with control group(p < 0.01). As expected, co-administration of CAPE ([CAPE] = 0.1, 1, 10 μmol/kg per day) lowered the level of PCO, and the higher dose of CAPE has the greater protective effect against Cd (II)-induced damage. These data indicated that CAPE showed the best protective capacities against protein damage induced by Cd (II) at the dose of 10 μmol/kg per day and these protection effects were dose-dependent. Fig. 4 . demonstrated that the effect of Cd (II) (1 mg/kg/day) for 7 days elevated the renal MDA level in Cd (II) group(p < 0.05,compared to control group). Again, the co-administration of different doses of CAPE ameliorated the increased level of MDA, especially at the dose of 10 μmol /kg per day, the MDA level was reduced to 55% (p < 0.001, compared to Cd (II) group). 
GSH, CAT and SOD
The administration of Cd (II)(1 mg/kg/day) for 7 days caused the marked decrease of GSH levels in Cd (II) group when comparing with control group (p < 0.001) (Fig. 5 ). However, this decreased level of GSH was ameliorated by the co-administration of different doses of CAPE (p < 0.05, p < 0.01, vs Cd (II) group).Data from Fig.6 revealed that the CAT activities in Cd (II) group have elevated by 54.9% (p < 0.001,compared to control group) after exposed to Cd (II)(1 mg/kg/day) for 7days, which may relate to an adaptive response to the renal damage. Co-administration of CAPE (0.1, 1, and 10 μmol/kg per day) can decrease the activities of CAT to 91.2%, 89.5%, and 89.5%, respectively (p < 0.05 compared to Cd (II) group). A marked decrease (p < 0.001, to 33% compared to control group) was found in the SOD activities in the kidney of Cd (II)-treated group of mice, and the co-treatment with different concentrations of CAPE can increase the SOD activities (p < 0.05, p < 0.01, compared to Cd (II) group) (Fig. 7) . Collectively, these results from both the oxidative damage parameters (PCO and MDA) and antioxidant defense system indexes (GSH, CAT and SOD) clearly suggested that CAPE has protective effects against Cd (II)-induced rental damage in mice.
Element analysis
To further investigate the protective role of CAPE on Cd (II)-induced rental damage, we next tested whether CAPE can affect the accumulation of Cd in kidney. Table 1 showed the accumulation of Cd in the kidney of all Cd (II)-exposed animals, 7 days after administration of Cd (II). As expected, a signifi cant elevated Cd concentration was observed in the Cd (II)-treated group (to 12 folds of control group, p < 0.01,compared with control group). Consistent well with the evidences obtained above, this accumulation was prevented in part by the co-treatment of CAPE at different doses and the content of Cd in the kidney was reduced to 66% compared to Cd (II) group when 0.1 μmol/kg per day CAPE(p < 0.05) was administrated.
Interestingly, the administration of Cd (II) also resulted in a decrease of Zn levels in the kidney of Cd (II)-exposed group (to 53.3% of control group, p < 0.05). However, the co-administration of CAPE at the dose of 0.1, 1 μmol/kg per day did not infl uence the action of Cd (II) in decreasing the Zn levels although Cd (II) alone reduced the content of Zn in the these two groups (to 39.9% and 64% of Control group, respectively, p < 0.05). On the other hand, higher dose of CAPE (10 μmol/kg per day) ameliorated the decrease of Zn content (to 82.9% of Control group, by 1.55 folds of Cd (II) group, p < 0.05).
MT levels in mouse kidney
MT is a small cysteine-rich protein and is believed to play a key role in the detoxication of heavy metals such as cadmium. To further elucidate the mechanism by which CAPE prevents Cd (II)-induced rental damage, we assessed the effect of CAPE on levels of MT in mouse kidney. As shown in the Figure 8 , an increase of MT content in Cd (II) group was observed (p < 0.05), whereas the treatment of CAPE had no influence on this effect compared to the Cd (II) group. This suggested that the protective effect of CAPE against Cd (II)-induced rental damage was through a not yet defined but MT-excluded mechanism.
DISCUSSION
Cd is a toxic trace metal and can be absorbed through lungs, gastrointestinal tract and skin. Following absorption, Cd is taken up by the hepatocytes and circulates in blood to bind to MT (Nordberg and Nordberg, 1987) . The Cd-MT complex, because of its small molecular size, is easily filtered through the glomerular membrane and taken up by renal tubular cells. Mt is then catabolized with the release of Cd ions in the cytoplasm where they induce synthesis of new Mt molecules. These new MT molecules, in turn, bind and retain Cd in the kidney. This explains why Cd has so long biological half life time and produce serious negative influence on kidney (Nordberg et al., 1994) . Various studies supported the proposed mechanism that increased oxidative stress induced by the interaction of Cd and mitochondrial structures resulted in renal damage (Tang and Shaikh, 2001) . Several studies have demonstrated that Cd exposure is associated to increased production of superoxide anion and nitric oxide (Hassoun and Stohs, 1996) and lipid peroxidation (Manca et al., 1991) and decreased tissue levels of GSH (Meister and Anderson, 1983) , despite the fact that Cd does not catalyze Fenton-type reactions.
Both acute and chronic Cd (II) exposure are associated with elevated LPO in tissues, an index of oxidative stress. Our data clearly indicated that Cd (II) intoxication induces oxidative stress (Fig. 3) . Similar data had been previously reported by Jurczuk et al. (2004) and Morales et al. (2006b) that Cd (II) increased LPO by a direct effect or by decreasing the GSH content. Giulivi and Davies (1994) reported that the formation of PCO is an important index of oxygen radial-mediated protein damage under various pathophysiological conditions. In this study, the increased production of PCO in Cd (II) group was an index of enhanced oxidative stress caused by Cd (II).
SOD is a natural antioxidant enzyme playing an important role in self-defense mechanisms of cells against oxidative stress. It converts the superoxide anion to less bioactive hydrogen peroxide and oxygen molecules. GSH plays a pivotal role in the defense against oxidative stress, as a cofactor of glutathione peroxidases (selenium dependent and independent) participates in the elimination of hydrogen peroxide and lipid hydroperoxides. In accordance with the previous studies, we have observed that renal content of SOD and GSH are decreased in mice exposed to Cd (II) (Fig. 4) . The effect of Cd (II) in decreasing renal SOD activities could be explained by two different ways. First, it has been already shown that renal toxics that increased oxygen free radical production are associated to decreased levels of antioxidant enzymes, such as SOD, GSH and GR (Thevenod, 2003) . Second, the inhibition of SOD activity might be a consequence of an interaction between Cd and Zn in SOD molecule since SOD contains Zn and Cu in its active site. Bauer et al. (1980) reported that 111 Cd was able to occupy the site of Zn in the CuZnSOD molecule creating an inactive form of the enzyme (Cu 111 CdSOD). Moreover, Cd is known to interfere with intracellular thiols by direct binding (Irano et al., 2001) . GSH depletion by Cd treatment can be either due to direct binding of the metal with GSH or due to leakage of GSH to the extracellular compartment. Hence, GSH is often the first line of defense against oxidative stress. GSH levels can be suppressed due to a severe oxidative stress. Similarly, Chin and Templeton (1993) proved that exposure to high doses of Cd (II) caused depletion of intracellular GSH due to ROS production. The depletion of the glutathione level in the present experiment is thus one of the factors responsible for enhanced lipid peroxidation. However, Cd (II) intoxication resulted in an enhancement of CAT activity in the kidney, which may reflect the adaptive response of ROS-mediated effects on enzymes through an increase in its synthesis. It was suggested that the enhancement of the activities of CAT is a renal-response to promote the detoxification process in this organ.
Another interesting finding of this study is that Cd (II) intoxication can disturb the cellular homeostasis of essential metal ions, especially Zn. This is consistent with that reported previously (Gong et al., 2008; Tandon et al., 2003) . It is well known that Zn is an essential component of the oxidant defense system, with participation at multiple cellular levels (Bray and Bettger, 1990) and acts as 122.9 ± 10.6** 21.9 ± 0.4* Cd (II)+CAPE 0.1 μmol /kg/day 81.6 ± 4.7* , # 16.4 ± 1.8* Cd (II)+CAPE 1 μmol /kg/day 87.5 ± 6.7* 26.3 ± 1.4 Cd (II)+CAPE 10 μmol /kg/day 95.7 ± 6.9* 34.1 ± 1.8#
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an indirect antioxidant by inducing the synthesis of metallothionein (Sato and Bremner, 1993) . The fact that the co-treatment with CAPE at the concentration of 0.1 and 1 μmol/kg/day can not ameliorate the reduction of Zn levels but improve the Zn content at the dose of 10 μmol/ kg/day, revealing the effect of CAPE on the disturbance of Zn content in vivo may be dose-dependent. Moreover, the concentration of Cd in the kidney has been tested, the highest concentration of Cd in the damage group revealed the accumulation of Cd in the kidney.
One of major purposes of our study is to assess if CAPE could modify the oxidative damage induced by Cd (II). We observed that different doses of CAPE administration significantly blunted Cd (II)-induced increase of renal TBARS and PCO, suggesting that CAPE reduced the production or levels of oxygen free radical in a manner of dose-dependent. The effect of CAPE also resulted in decrease in renal content of SOD and GSH, and elevation of CAT activity compared with Cd (II)-exposed group, revealing that CAPE may play as the antioxidant partly replacement of the role of CAT, SOD or GSH. These data provided evidences that the protective effects of CAPE seem to be mediated at least in part by its antioxidant properties.
CAPE is an active component of honeybee propolis extracts and has been used in traditional medicine for many years. At a concentration of 10 μM, CAPE exhibited its anti-inflammatory effect by completely blocking production of reactive oxygen species in human neutrophils and xanthine/xanthine oxidase system. Our group has demonstrated that the structural features responsible for the antioxidative and free radical scavenging activity of CAPE is the ortho-dihydroxyl functionality in the catechol ring (Wu et al., 2007) . As shown in Fig.1 , the presence of the electron-donating hydroxyl group at the ortho-position would make the oxidation intermediate and increase the rate of H-atom transfer to peroxyl radicals (Lucarini et al., 2002) , leading to the formation of a phenoxy radical. The ortho-hydroxyl phenoxyl radical is more stable due to (1) the unpaired electron can delocalize across the entire molecule; (2) the intramolecular hydrogen bonding interaction as reported recently from both experiments (Chen and Ho, 1997) and theoretical calculations (Wright et al., 2001) . The theoretical calculation showed that the intramolecular hydrogen bond in ortho-OH phenoxyl radical is ca. 16.7 kJ/mol stronger than that in the parent molecule catechol and the bond dissociation energy of catechol is 38 kJ/mol lower than that of phenol and 36.8 kJ/mol lower than that of resorcinol. In addition, ortho-OH phenoxyl radical and/or orthosemiquinone radical anion shall be easier to further oxidize to form the final product ortho-quinone. Kim et al. (1999) have suggested that the reduction of endogenous Zn levels may relate to the activation of nuclear factor kappa beta (NF-κB). NF-κB activation is a common pathway that mediates the upregulation of genes encoding for inflammatory mediators such as adhesion molecules and proinflammatory cytokines. Moreover, NF-κB activation is thought to link with oxidative stress, cytotoxic cytokines and liver cell necrosis (Liu et al., 1995) . CAPE is a well-documented inhibitor of NF-κB (Abdel-Latif et al., 2005; Natarajan et al., 1996) , by intervening in IKK-IκBα-p65 pathway or activating nuclear factor erythroid 2 related factor 2 (Nrf2) (Ang et al., 2009; Onori et al., 2009; Toyoda et al., 2009; Lee et al., 2010) . Nrf2, an important cytoprotective transcription factor, binds to antioxidant responsive element and is a chief regulator of a battery of cytoprotective genes. Cd stabilizes Nrf2 and prevents its degradation via the ubiquitin proteasome in mouse hepatoma cells (Stewart et al., 2003) and mouse embryonic fibroblasts (He et al., 2008) . Nrf2 is also activated by Cd in vivo (Abu-Bakar et al., 2004; Casalino et al., 2007) and in cultured cells such as vascular endothelial cells (Sakurai et al., 2005) , mouse embryonic fibroblasts (He et al., 2008) and rat kidney cell (Chen and Shaikh, 2009 ). Lee et al. (2010) reported that the functional groups, catechol and Michael reaction acceptor in CAPE, collaborate to interfere with NF-κB activation probably via IKK inhibition and Nrf2 activation. Catechol forms semiquinones and reactive quinones that are presumed to play an important role in the production of ROS tomodulate Nrf2 and NF-κB activity (Baulig et al., 2003; Christman et al., 2000) . Quinones generated from catechol and the α,β-unsaturated carbonyl moiety in the CAPE are capable to act as an electrophile that may react with the sulfhydryl residues of Keap1, the cytosolic repressor of Nrf2, resulting in activation of Nrf2 (Satoh et al., 2008) . The phenethyl moiety and the aromatic ring are also likely to affect potency of CAPE in intervening NF-κB activity probably via modulating lipophilic interaction with other potential molecular target(s). Taken together, the inhibitory effects of CAPE on NF-κB expression via activation of Nrf2 pathway may act as, at least in part, an action mechanism to reduce Cd (II)-induced renal damage (Natarajan et al., 1996) .
MT, a small cysteine-rich protein, is believed to play a key role in diverse biological processes, including the detoxication of heavy metals such as cadmium, homeostasis of essential metals and scavenging of free radicals. Exogenous MT has been described to protect against acute renal and liver cadmium toxicity in rats, probably based on its antioxidant properties (Kara et al., 2005) .
Chronic administration of Cd to rats was associated with increased MT expression in kidney, and administration of quercetin had a marked protective effect on Cd-induced nephrotoxicity (Morales et al., 2006a) . However, the present result showed no significant change of MT content after co-treatment with CAPE.
A not yet defined but MT-independent pathway explains the protection effect of CAPE against the nephrotoxicity.
In summary, we reported that CAPE protects the oxidative renal damage induced by Cd (II) in a dose-dependent manner through reducing the levels of oxidative stress and altering the antioxidant defense system. The underlying mechanism is proposed to associate with its antioxidant capacity, anti-inflammatory effect and the capacity to intervene NF-κB expression via activation of Nrf2 pathway. MT is not involved into the protective action of CAPE on the Cd (II)-induced rental damage. The detailed molecular mechanism is still unclear and further studies are needed. Overall, this study provides some evidences for the detailed mechanism of Cd (II) on renal toxicity and new utilization of CAPE, and will stimulate further research into the roles and mechanisms of CAPE in its beneficial effects.
